The Organ-Sparing Miracle and the Hepatic Cost: Analyzing Dostarlimab’s FDA Accelerated Approval for Rectal Cancer
The Organ-Sparing Miracle and the Hepatic Cost: Analyzing Dostarlimab’s FDA Accelerated Approval for Rectal Cancer
avoiding surgery and radiation in rectal cancer with dostarlimab